ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Critical Care Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,511Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 18

$1.05M Total Retail Price of All Prescriptions

Rank: 2 out of 18

728 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 728 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 7,437 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 50%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $129 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SINGULAIR 869 691 1 4
MONTELUKAST SODIUM 667 504 10 2 9
THEOPHYLLINE ANHYDROUS 596 435 10 3 8
OMEPRAZOLE 558 455 4 5
HYDROCODONE-ACETAMINOPHEN 456 271 S3 5 15
FUROSEMIDE 354 247 6 10
SPIRIVA 318 222 7 1
LOSARTAN POTASSIUM 274 183 8 18
PREDNISONE 274 193 8 2
COMBIVENT 263 146 10 14
ADVAIR DISKUS 213 147 11 3
THEO-24 206 181 10 12 25
ADVAIR HFA 188 150 13 21
SYMBICORT 175 126 14 6
DOXYCYCLINE HYCLATE 170 120 15 29
POTASSIUM CHLORIDE 155 128 16 27
AMLODIPINE BESYLATE 143 114 17 20
NEXIUM 142 125 18 13
DOXAZOSIN MESYLATE 133 94 19 37
SPIRONOLACTONE 125 91 20 38
WARFARIN SODIUM 123 84 21 23
AZITHROMYCIN 109 88 22 12
ZOLPIDEM TARTRATE 102 63 23 19
GABAPENTIN 99 54 24 34
ATENOLOL 93 87 25 43
METHYLPREDNISOLONE 84 61 26 36
CARISOPRODOL 75 30 R 27 44
METOPROLOL TARTRATE 74 56 28 26
VENTOLIN HFA 72 28 29 11
METOCLOPRAMIDE HCL 72 55 29 45
SERTRALINE HCL 69 53 31 39
LEVOFLOXACIN 68 50 32 16
ZAFIRLUKAST 62 42 33 51
DULERA 61 43 34 40
CIPROFLOXACIN HCL 60 35 35 33
ALLOPURINOL 60 56 35 53
NAMENDA 57 48 37 56
CARVEDILOL 55 53 38 41
PROAIR HFA 54 29 39 7
PANTOPRAZOLE SODIUM 53 43 40 22
ESCITALOPRAM OXALATE 52 21 41 59
FLUCONAZOLE 51 27 42 60
DOXEPIN HCL 50 26 43 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.